Hasil Pencarian - Markus Dietlein
- Menampilkan 1 - 19 hasil dari 19
-
1
Mediastinal goiter diagnosed by functional imaging oleh Guido Michels, Markus Dietlein, Carsten Kobe, Roman Pfister
Diterbitkan 2012-01-01Dapatkan teks lengkap
Artikel -
2
From Bench to Bedside: Patient-Oriented Radiopharmaceutical Development in Nuclear Medicine Based on the Example of [<sup>89</sup>Zr]Zr-PSMA-DFO oleh Klaus Schomäcker, Felix Dietlein, Sergio Muñoz Vázquez, Feodor Braun, Thomas Fischer, Philipp Krapf, Alexander Drzezga, Markus Dietlein
Diterbitkan 2023-12-01Dapatkan teks lengkap
Artikel -
3
Threshold for defining PSMA-positivity prior to 177Lu-PSMA therapy: a comparison of [68Ga]Ga-PSMA-11 and [18F]F-DCFPyL in metastatic prostate cancer oleh Jan Heilinger, Jasmin Weindler, Katrin Sabine Roth, Philipp Krapf, Klaus Schomäcker, Markus Dietlein, Alexander Drzezga, Carsten Kobe
Diterbitkan 2023-09-01Dapatkan teks lengkap
Artikel -
4
The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered oleh Peter Borchmann, Alexander Fosså, Monika Długosz-Danecka, Boris Böll, Markus Dietlein, Carsten Kobe, Helen Goergen, Andreas Engert
Diterbitkan 2018-06-01Dapatkan teks lengkap
Artikel -
5
Case report: Use of 68Ga-DOTATATE-PET for treatment guidance in complex meningioma disease oleh Anna-Katharina Meißner, Niklas von Spreckelsen, Abdulkader Al Shughri, Anna Brunn, Gina Fuertjes, Marc Schlamann, Marc Schlamann, Matthias Schmidt, Matthias Schmidt, Markus Dietlein, Markus Dietlein, Daniel Rueß, Daniel Rueß, Maximilian I. Ruge, Maximilian I. Ruge, Norbert Galldiks, Norbert Galldiks, Norbert Galldiks, Roland Goldbrunner, Roland Goldbrunner
Diterbitkan 2022-10-01Dapatkan teks lengkap
Artikel -
6
Impact of different approaches to calculation of treatment activities on achieved doses in radioiodine therapy of benign thyroid diseases oleh Jochen Hammes, Lutz van Heek, Melanie Hohberg, Manuel Reifegerst, Simone Stockter, Markus Dietlein, Markus Wild, Alexander Drzezga, Matthias Schmidt, Carsten Kobe
Diterbitkan 2018-12-01Dapatkan teks lengkap
Artikel -
7
Localization and Tumor Growth Inhibition of I-131-Labeled Monoclonal Antibody ERIC1 in a Subcutaneous Xenograft Model of Small Cell Lung Cancer in SCID Mice oleh Thomas Fischer, Christopher Dietrich, Felix Dietlein, Sergio Muñoz Vázquez, Beate Zimmermanns, Philipp Krapf, Ferdinand Sudbrock, Alexander Drzezga, Markus Dietlein, Klaus Schomäcker
Diterbitkan 2024-10-01Dapatkan teks lengkap
Artikel -
8
T020: Interim PET-guided treatment of early-stage nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the GHSG HD16 and HD17 studies oleh Dennis A. Eichenauer, Ina Bühnen, Michael Fuchs, Richard Greil, Alden Moccia, Josée. M. Zijlstra, Sylvia Hartmann, Carsten Kobe, Markus Dietlein, Andreas Engert, Peter Borchmann
Diterbitkan 2022-10-01Dapatkan teks lengkap
Artikel -
9
Uptake in non-affected bone tissue does not differ between [18F]-DCFPyL and [68Ga]-HBED-CC PSMA PET/CT. oleh Jochen Hammes, Melanie Hohberg, Philipp Täger, Markus Wild, Boris Zlatopolskiy, Philipp Krapf, Bernd Neumaier, Klaus Schomäcker, Carsten Kobe, Matthias Schmidt, Markus Dietlein, Alexander Drzezga
Diterbitkan 2018-01-01Dapatkan teks lengkap
Artikel -
10
Tumoricidal Activity and Side Effects of Radiolabeled Anti-NCAM [<sup>131</sup>I]-Iodine-ERIC1 in Neuroblastoma-Bearing Mice oleh Thomas Fischer, Felix Dietlein, Detlev Bongartz, Martin Klehr, Beate Zimmermanns, Matthias Schmidt, Angela Mohr, Fabian Mohr, Ferdinand Sudbrock, Philipp Krapf, Alexander Drzezga, Markus Dietlein, Klaus Schomäcker
Diterbitkan 2024-10-01Dapatkan teks lengkap
Artikel -
11
P024: Predictive Value of Baseline Metabolic Tumor Volume in Early-Stage Favorable Hodgkin Lymphoma – Data from the Prospective, Multicenter Phase III HD16 Trial oleh Lutz Van Heek, Colin Stuka, Helen Kaul, Horst Müller, Jasmin Mettler, Felicitas Hitz, Christian Baues, Michael Fuchs, Peter Borchmann, Andreas Engert, Markus Dietlein, Conrad-Amadeus Voltin, Carsten Kobe
Diterbitkan 2022-10-01Dapatkan teks lengkap
Artikel -
12
P008: Impact of bone marrow involvement on early PET response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma oleh Conrad-Amadeus Voltin, Stefanie Kreissl, Helen Kaul, Ina Bühnen, Jasmin Mettler, Thomas Pabst, Dennis A. Eichenauer, Michael Fuchs, Volker Diehl, Markus Dietlein, Andreas Engert, Peter Borchmann, Carsten Kobe
Diterbitkan 2022-10-01Dapatkan teks lengkap
Artikel -
13
Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma – Data from the prospective, multicenter phase III HD16 trial oleh Lutz van Heek, Colin Stuka, Helen Kaul, Horst Müller, Jasmin Mettler, Felicitas Hitz, Christian Baues, Michael Fuchs, Peter Borchmann, Andreas Engert, Markus Dietlein, Conrad-Amadeus Voltin, Carsten Kobe
Diterbitkan 2022-06-01Dapatkan teks lengkap
Artikel -
14
Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD oleh Nils Richter, Nils Nellessen, Julian Dronse, Kim Dillen, Heidi I.L. Jacobs, Karl-Josef Langen, Markus Dietlein, Lutz Kracht, Bernd Neumaier, Gereon R. Fink, Juraj Kukolja, Oezguer A. Onur
Diterbitkan 2019-01-01Dapatkan teks lengkap
Artikel -
15
Biodistribution and radiation dosimetry of [18F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer oleh Melanie Hohberg, Carsten Kobe, Philipp Krapf, Philipp Täger, Jochen Hammes, Felix Dietlein, Boris D. Zlatopolskiy, Heike Endepols, Markus Wild, Stephan Neubauer, Axel Heidenreich, Bernd Neumaier, Alexander Drzezga, Markus Dietlein
Diterbitkan 2019-07-01Dapatkan teks lengkap
Artikel -
16
Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinib. oleh Matthias Scheffler, Thomas Zander, Lucia Nogova, Carsten Kobe, Deniz Kahraman, Markus Dietlein, Irini Papachristou, Lukas Heukamp, Reinhard Büttner, Ron Boellaard, Adriaan A Lammertsma, Silvia Querings, Erich Stoelben, Walburga Engel-Riedel, Bernd Neumaier, Jürgen Wolf
Diterbitkan 2013-01-01Dapatkan teks lengkap
Artikel -
17
Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma. oleh Regine Kluge, Lidia Chavdarova, Martha Hoffmann, Carsten Kobe, Bogdan Malkowski, Françoise Montravers, Lars Kurch, Thomas Georgi, Markus Dietlein, W Hamish Wallace, Jonas Karlen, Ana Fernández-Teijeiro, Michaela Cepelova, Lorrain Wilson, Eva Bergstraesser, Osama Sabri, Christine Mauz-Körholz, Dieter Körholz, Dirk Hasenclever
Diterbitkan 2016-01-01Dapatkan teks lengkap
Artikel -
18
Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma oleh Andreas Engert, Helen Goergen, Jana Markova, Thomas Pabst, Julia Meissner, Josée M. Zijlstra, Zdenek Král, Dennis A. Eichenauer, Martin Soekler, Richard Greil, Stefanie Kreissl, Ruth Scheuvens, Hans Eich, Carsten Kobe, Markus Dietlein, Harald Stein, Michael Fuchs, Volker Diehl, Peter Borchmann
Diterbitkan 2017-12-01Dapatkan teks lengkap
Artikel -
19
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy oleh Conrad-Amadeus Voltin, Philipp Gödel, Laura Beckmann, Jan-Michel Heger, Carsten Kobe, Nadine Kutsch, Peter Borchmann, Markus Dietlein, Ken Herrmann, Matthias Stelljes, Kambiz Rahbar, Georg Lenz, H. Christian Reinhardt, Marcel Teichert, Richard Noppeney, Jörn C. Albring, Robert Seifert, Bastian von Tresckow, Sarah Flossdorf, Christine Hanoun
Diterbitkan 2023-01-01Dapatkan teks lengkap
Artikel